IDXX vs KLRS
IDEXX Laboratories Inc (IDXX) versus Kalaris Therapeutics, Inc. (KLRS) — a side-by-side from cached financials, not a winner call.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Kalaris Therapeutics, Inc. (KLRS) is a biotechnology company listed on US.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
KLRS does not have a complete income-statement cache yet.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. KLRS currently screens at market cap $0.
Not investment advice. Open the IDXX and KLRS stock pages for the full models.
Not investment advice.